Itaconix plc ("Itaconix" or the "Company")
Itaconix and AkzoNobel move from the technical evaluation phase to defining a joint marketing effort for Itaconix bio-based chelates
Itaconix is pleased to announce that following a successful technical and regulatory evaluation, AkzoNobel's Chelates' business has formally notified Itaconix of its intention to enter into a joint marketing effort related to Itaconix's innovative bio-based chelates for use in the consumer and industrial detergents and cleaners markets.
This latest development follows from the initial announcement in September 2017 that AkzoNobel's Specialty Chemicals business would commence the technical evaluation of Itaconix's bio-based chelates. Although commercial details remain to be finalised, both parties target to complete final agreements before the end of 2018. The goal is to establish a strong multi-year relationship to deliver Itaconix's innovative bio-based chelates to customers worldwide, thereby supporting the development of high performance, sustainable, consumer products using Itaconix technology.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).
Ends
For further information please contact:
Itaconix |
+44 (0) 1244 283 500 |
Kevin Matthews / Rob Cridland |
|
N+1 Singer |
+44 (0) 207 496 3000 |
Richard Lindley / Jen Boorer (Corporate Finance)
|
|
Charlie Jack / Emily Dillon +44 (0) 207 796 4133
Itaconix is developing proprietary active ingredients that meet the performance and price needs of its customers and offers them improved safety and sustainability, thereby helping to deliver on the global sustainability agenda, with particular emphasis on the Personal Care and Homecare markets.